Summary & Overview
HCPCS Level II Q9987: Platelet Pathogen Testing
HCPCS Level II code Q9987 denotes laboratory testing for pathogens in platelet units prior to transfusion. This service is clinically important because platelet components carry a higher risk of bacterial contamination than other blood products; testing helps reduce transfusion-transmitted infections and supports safe blood supply practices. Nationally, pathogen testing for platelets intersects with hospital transfusion protocols, blood center operations, and payer coverage policies.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what Q9987 represents, how it is used across typical sites of service such as hospital and commercial laboratories, and the broader clinical rationale for pretransfusion platelet testing. The publication also outlines what to expect in benchmarking and policy contexts: common reimbursement considerations, implications for blood banks and transfusion services, and connections to laboratory and hospital service lines.
The content is designed to help administrators, billing staff, and policy analysts understand the code’s clinical purpose and placement within payer coverage frameworks. Data elements not provided in the source (such as specific modifiers, associated taxonomies, ICD-10 diagnoses, and related codes) are indicated as unavailable where relevant.
Billing Code Overview
HCPCS Level II code Q9987 represents a pathogen(s) test for platelets. This code describes laboratory testing performed to detect bacterial, viral, or other pathogenic contamination of platelet units prior to transfusion.
-
Service type: Laboratory diagnostic testing of blood products (platelet pathogen testing)
-
Typical site of service: Blood bank, hospital laboratory, transfusion service, or specialized commercial laboratory
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient scheduled to receive a pooled platelet transfusion prior to an urgent surgical procedure undergoes pathogen testing of the platelet unit to reduce risk of transfusion-transmitted infections. The hospital transfusion service or affiliated blood bank receives donor platelet units and performs nucleic acid amplification testing and bacterial culture-based screening per institutional and regulatory protocols. Results are documented in the transfusion record and communicated to the perioperative team; pathogen-tested platelets are labeled for release and delivered to the operating room or inpatient unit for administration under the blood bank’s release protocols. Typical site of service is a hospital-based blood bank or transfusion service supporting inpatient, operating room, or outpatient infusion center settings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | Use if a separate unrelated procedure is performed on the same date that should be billed separately from the platelet pathogen test |
76 | Repeat procedure or service by same physician | Use when the platelet pathogen test is repeated by the same provider on the same day |